• Caffeic Acid Phenethyl Ester in NF-κB Research

  2026-08-29

  Caffeic Acid Phenethyl Ester (CAPE) provides a practical chemical perturbation for separating NF-κB-dependent inflammation from Stat3-linked neurodegeneration. This workflow connects zebrafish live imaging and cytokine assays with CAPE anti-angiogenesis research, while emphasizing controls for solubility, timing, toxicity, and pathway specificity.

• (-)-JQ1: BET Inactive Control Workflows

  2026-08-28

  Use (-)-JQ1, the inactive JQ1 stereoisomer, to separate BET-dependent biology from solvent, handling, and compound-exposure artifacts. A matched workflow is especially valuable for HPV-associated HNSCC experiments measuring viral transcription, BRD4-linked cellular genes, cell-cycle arrest, and apoptosis.

• Macrophage EP4 Loss Accelerates Atherosclerosis

  2026-08-28

  Tang and colleagues identify macrophage EP4 as a protective regulator of atherosclerosis and connect its loss to increased CD36 expression, foam-cell formation, and M1 polarization. By combining a myeloid-specific knockout model with oxLDL-stimulated cells and transcriptomic, proteomic, qPCR, and immunoblot analyses, the study provides a mechanistic framework for understanding how prostaglandin signaling influences inflammatory lipid handling.

• Vemurafenib (PLX4032, RG7204) in Cell Assays

  2026-08-27

  A scenario-driven guide to using Vemurafenib (PLX4032, RG7204), SKU A3004, in melanoma viability, proliferation, and resistance experiments. It connects BRAF V600E biology with practical handling, genotype controls, resistance interpretation, and evidence-based product selection.

• α-Linolenic Acid Research Workflows

  2026-08-27

  Build reproducible ALA experiments around lipid handling, dose-response design, and oxidation control. This guide connects α-Linolenic Acid workflows with cardiovascular, inflammation, cancer, and immune assays while clearly separating established evidence from testable research extensions.

• Verbascoside for PKC/NF-κB Assays

  2026-08-26

  Verbascoside provides a practical chemical perturbation strategy for connecting PKC/NF-κB activity with osteoclast differentiation, inflammatory signaling, and cell–cell communication assays. This workflow combines dose–response design, orthogonal readouts, and a cautious translational bridge to trigeminal ganglion research.

• Canine Osteosarcoma Cells: NSAID Cytotoxicity Study

  2026-08-26

  This 2005 study compared deracoxib and piroxicam in three canine osteosarcoma cell lines and a fibroblast line, showing that deracoxib reduced tumor-cell viability more consistently than piroxicam in vitro. The findings also separated cytotoxicity from DNA-fragmentation evidence of apoptosis and showed that effective concentrations were higher than typical canine plasma exposures.

• E-4031 for Reliable hERG Assays

  2026-08-25

  Learn how E-4031 (SKU B6077) can help biomedical researchers separate electrophysiological effects from nonspecific loss of cell viability. This scenario-driven guide covers assay compatibility, concentration planning, interpretation, and practical reagent selection for cardiac electrophysiology research.

• Thiothixene Drives Continual Macrophage Efferocytosis

  2026-08-25

  A 2025 Science Signaling study identified Thiothixene as a repurposing candidate that enhances macrophage efferocytosis of apoptotic and lipid-laden cells. The work links this activity to Stra6L-dependent vitamin A signaling and Arginase 1 induction, while showing that dopamine suppresses efferocytosis and is only partly counteracted by Thiothixene.

• 10 mM dNTP Mixture for PCR and LNP Studies

  2026-08-24

  Build reproducible PCR, qPCR, sequencing, and DNA-construction workflows with a precisely balanced nucleotide stock. This guide also shows how dNTP-controlled assay design can strengthen mechanistic studies of LNP delivery without confusing DNA synthesis reagents with nanoparticle formulation components.

• Docetaxel Assays: From Mitotic Arrest to Translation

  2026-08-24

  Docetaxel research is strongest when mitotic arrest, apoptosis, formulation, and assay timing are interpreted together. This guide presents a measurement-centered framework for using Docetaxel in cancer chemotherapy research while separating direct tumor-cell effects from treatment-context variables.

• Direct Mouse Genotyping Kit Plus: From Genotype to Phenotype

  2026-08-23

  The Direct Mouse Genotyping Kit Plus connects rapid PCR-based mouse genotyping with more rigorous genotype-to-phenotype study design. Learn how its direct lysate workflow can support transgene detection, colony screening, and interpretation of SCA3 mouse experiments without confusing genotype confirmation with therapeutic evidence.

• Angiotensin 1/2 (2-7) Research Workflows

  2026-08-22

  Angiotensin 1/2 (2-7) supports sequence-defined studies of vasoconstriction, aldosterone release, and renin-angiotensin signaling. Its shorter-fragment design also enables focused comparison in spike–receptor binding assays, where peptide length can alter assay behavior.

• Nystatin (Fungicidin): Assay Workflows

  2026-08-22

  Turn Nystatin (Fungicidin) into a reproducible benchmark for Candida susceptibility, adhesion, and biofilm experiments. This workflow-centered guide also explains how the reference study used ergosterol biology to improve polyene assay design and how to troubleshoot solubility, dosing, and model-dependent variability.

• 5-Methyl-CTP for Stable mRNA Workflows

  2026-08-21

  5-Methyl-CTP helps researchers build mRNA synthesis workflows that prioritize transcript persistence and translation while preserving a controlled experimental comparison with conventional CTP. This guide connects nucleotide-level optimization with the plug-and-display bacterial outer membrane vesicle strategy reported for personalized tumor vaccines.

8445 records 1/563 page Next 12345 下5页 Last page